Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice

[1]  C. Ackerley,et al.  Effects of purine nucleoside phosphorylase deficiency on thymocyte development. , 2011, The Journal of allergy and clinical immunology.

[2]  V. Micheli,et al.  Neurological disorders of purine and pyrimidine metabolism. , 2011, Current topics in medicinal chemistry.

[3]  L. Xiong,et al.  TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke , 2011, Journal of drug targeting.

[4]  J. Cendelin,et al.  Ataxic gait analysis in a mouse model of the olivocerebellar degeneration , 2010, Behavioural Brain Research.

[5]  H. Jinnah.  Lesch-Nyhan disease: from mechanism to model and back again , 2009, Disease Models & Mechanisms.

[6]  N. Liadis,et al.  Excitatory tonus is required for the survival of granule cell precursors during postnatal development within the cerebellum , 2009, Neuroscience.

[7]  Josselyn Sheena,et al.  Selective erasure of a fear memory , 2009 .

[8]  Baoquan Zhao,et al.  Transducible P11-CNTF rescues the learning and memory impairments induced by amyloid-beta peptide in mice. , 2008, European journal of pharmacology.

[9]  J. Crabbe,et al.  Motor impairment: a new ethanol withdrawal phenotype in mice , 2008, Behavioural pharmacology.

[10]  L. Wilkinson,et al.  P-Rex2 regulates Purkinje cell dendrite morphology and motor coordination , 2008, Proceedings of the National Academy of Sciences.

[11]  R. Mark Henkelman,et al.  Automated deformation analysis in the YAC128 Huntington disease mouse model , 2008, NeuroImage.

[12]  S. Grafakos,et al.  Successful HLA‐identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency , 2007, Pediatric transplantation.

[13]  Afra H. Wang,et al.  Imaging activation of adult-generated granule cells in spatial memory , 2007, Nature Protocols.

[14]  J. Mariani,et al.  Oxidative stress, nitric oxide, and the mechanisms of cell death in Lurcher Purkinje cells , 2007, Developmental neurobiology.

[15]  F. Vardar,et al.  Purine Nucleoside Phosphorylase Deficiency in a Patient With Spastic Paraplegia and Recurrent Infections , 2007, Journal of child neurology.

[16]  R. Mark Henkelman,et al.  Sexual dimorphism revealed in the structure of the mouse brain using three-dimensional magnetic resonance imaging , 2007, NeuroImage.

[17]  E. Grunebaum,et al.  TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice. , 2006, The Journal of clinical investigation.

[18]  C. Ackerley,et al.  Intracellular delivery of purine nucleoside phosphorylase (PNP) fused to protein transduction domain corrects PNP deficiency in vitro. , 2006, Cellular immunology.

[19]  J. Kurtzberg,et al.  Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation. , 2004, The Journal of pediatrics.

[20]  M. Lavin,et al.  Oxidative Stress Is Responsible for Deficient Survival and Dendritogenesis in Purkinje Neurons from Ataxia-Telangiectasia Mutated Mutant Mice , 2003, The Journal of Neuroscience.

[21]  R. A. Zimmerman,et al.  Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI , 2003, Neuroradiology.

[22]  J. Crabbe,et al.  A mouse model of episodic ataxia type-1 , 2003, Nature Neuroscience.

[23]  M. Dogui,et al.  Familial Spastic Paraplegia as the Presenting Manifestation in Patients With Purine Nucleoside Phosphorylase Deficiency , 2003, Journal of child neurology.

[24]  J. Whitton,et al.  Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity , 2002, Gene Therapy.

[25]  K. Dahan,et al.  Persistent developmental delay despite successful bone marrow transplantation for purine nucleoside phosphorylase deficiency. , 2002, Journal of pediatric hematology/oncology.

[26]  H. Simmonds,et al.  Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning , 2001, Bone Marrow Transplantation.

[27]  A. Cohen,et al.  Two novel mutations in a purine nucleoside phosphorylase (PNP)‐deficient patient , 2001, Clinical genetics.

[28]  Pier Paolo Pandolfi,et al.  Mitochondrial Basis for Immune Deficiency , 2000, The Journal of experimental medicine.

[29]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[30]  Y. Hirabayashi,et al.  An improved method for culturing cerebellar Purkinje cells with differentiated dendrites under a mixed monolayer setting. , 1998, Brain research. Brain research protocols.

[31]  J. Roder,et al.  Reduction of Lower Motor Neuron Degeneration inwobbler Mice byN-Acetyl-l-Cysteine , 1996, The Journal of Neuroscience.

[32]  Markert Ml.  Purine nucleoside phosphorylase deficiency. , 1991, Immunodeficiency reviews.

[33]  M. Markert,et al.  Purine nucleoside phosphorylase deficiency , 2020, Atlas of Inherited Metabolic Diseases.

[34]  H. Simmonds,et al.  Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency. , 1987, Archives of disease in childhood.

[35]  K. Rich,et al.  Purine nucleoside phosphorylase deficiency: improved metabolic and immunologic function with erythrocyte transfusions. , 1980, The New England journal of medicine.